The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-[1'-(1-cyclopropyl-4-methoxy-3-methyl-indole-6-carbonyl)-4-oxo-spiro[chromane-2,4'-piperidine]-6-yl]pyridine-3-carboxylic acid ID: ALA4557289
Cas Number: 1039758-22-9
PubChem CID: 24964679
Product Number: M651318, Order Now?
Max Phase: Preclinical
Molecular Formula: C33H31N3O6
Molecular Weight: 565.63
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(C(=O)N2CCC3(CC2)CC(=O)c2cc(-c4cncc(C(=O)O)c4)ccc2O3)cc2c1c(C)cn2C1CC1
Standard InChI: InChI=1S/C33H31N3O6/c1-19-18-36(24-4-5-24)26-13-21(14-29(41-2)30(19)26)31(38)35-9-7-33(8-10-35)15-27(37)25-12-20(3-6-28(25)42-33)22-11-23(32(39)40)17-34-16-22/h3,6,11-14,16-18,24H,4-5,7-10,15H2,1-2H3,(H,39,40)
Standard InChI Key: WDBNGXLHMZSUEI-UHFFFAOYSA-N
Molfile:
RDKit 2D
42 48 0 0 0 0 0 0 0 0999 V2000
23.3752 -4.7283 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0832 -4.3169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7915 -4.7277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7915 -5.5431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0858 -5.9537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3752 -5.5483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4996 -5.9549 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.2077 -5.5431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2077 -4.7278 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4996 -4.3160 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4996 -3.4965 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.9157 -5.1354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6238 -5.5431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6238 -6.3626 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.9157 -6.7744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2077 -6.3626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3360 -6.7744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0440 -6.3626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0444 -5.5430 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7499 -5.1381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4624 -5.5459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4605 -6.3637 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7565 -6.7769 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2384 -6.6141 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.7147 -5.9515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2348 -5.2954 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4469 -4.5035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4505 -7.4019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2379 -8.1960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0295 -7.9827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7499 -4.3186 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.0419 -3.9109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3360 -7.5938 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.6630 -4.3165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9547 -4.7280 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2503 -4.3171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2503 -3.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9563 -3.0906 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.6630 -3.4961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5381 -4.7289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5381 -5.5442 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.8300 -4.3171 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
6 5 2 0
1 6 1 0
4 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
3 10 1 0
10 11 2 0
8 12 1 0
13 12 1 0
14 13 1 0
15 14 1 0
16 15 1 0
8 16 1 0
14 17 1 0
17 18 1 0
19 18 2 0
20 19 1 0
21 20 2 0
22 21 1 0
23 22 2 0
18 23 1 0
22 24 1 0
25 24 1 0
26 25 2 0
21 26 1 0
26 27 1 0
24 28 1 0
29 28 1 0
29 30 1 0
28 30 1 0
20 31 1 0
31 32 1 0
17 33 2 0
34 1 1 0
35 34 2 0
36 35 1 0
37 36 2 0
38 37 1 0
39 38 2 0
34 39 1 0
36 40 1 0
40 41 2 0
40 42 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 565.63Molecular Weight (Monoisotopic): 565.2213AlogP: 5.69#Rotatable Bonds: 5Polar Surface Area: 110.96Molecular Species: ACIDHBA: 7HBD: 1#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: 3.98CX Basic pKa: 2.62CX LogP: 3.18CX LogD: 0.28Aromatic Rings: 4Heavy Atoms: 42QED Weighted: 0.33Np Likeness Score: -0.45
References 1. Romero FA, Jones CT, Xu Y, Fenaux M, Halcomb RL.. (2020) The Race to Bash NASH: Emerging Targets and Drug Development in a Complex Liver Disease., 63 (10): [PMID:31930920 ] [10.1021/acs.jmedchem.9b01701 ]